Parabilis Medicines, NewLimit, Enliven Therapeutics, and Kardigan bagged the biggest biotech funding rounds overall in June 2026.

Delve into Roche's strategy, a company originally built on oncology, now reinventing its pipeline in obesity and immunology.

Find out what Novartis' pipeline strategy since it spun off its biosimilars and generics business Sandoz, and engage in ...

Delve into bronchiectasis, a field long focused on managing symptoms that now has its first targeted treatment with ...

Discover Prague's biotech hub, now viewed as the primary ‘entry gateway’ into the wider Central and Eastern European ...

Discover why animal models fall short in AI drug discovery and how human-first datasets and functional genomics are changing ...

The European life science sector remains a key driver of global innovation that is propelled by technological breakthroughs and a robust pipeline of novel therapies. But the European Union (EU) is ...

Home to the European Commission (EC), Belgium holds a reputation for life sciences and innovation in Europe. In the port city of Ghent, the Vlaams Instituut voor Biotechnologie (VIB) wants to bridge ...

What readers will learn: Reduce manual effort through one automated, closed T cell manufacturing workflow, transferred across multiple sites with reproducible outcomes. Strengthen QC readiness through ...

For some biotech companies, a rebrand is the public face of a strategic restructuring after years of pursuing a business model that failed to deliver on its promise. For others, it marks a dramatic ...

Daiichi Sankyo has recently set out on an ambitious strategic aim. Having established itself as a leader in antibody-drug conjugates (ADCs) through the success of its blockbuster drug Enhertu, the ...